Shusen Zheng
Zhejiang University
916 Papers
3.3K Citations
Shusen Zheng is an academic researcher from Zhejiang University. The author has contributed to research in topics: Liver transplantation & Medicine. The author has an hindex of 52, co-authored 814 publications. Previous affiliations of Shusen Zheng include Peking Union Medical College & Democratic Republic of the Congo Ministry of Health.
Chat about Author
Papers
A Novel WRN Frameshift Mutation Identified by Multiplex Genetic Testing in a Family with Multiple Cases of Cancer
TL;DR: The results suggest that the WRN frameshift mutation is important in the surveillance of other members of this family, especially the youngest daughter, but the pathogenicity of the novel WRN framing mutation needs to be investigated further.
KLF14 regulates the growth of hepatocellular carcinoma cells via its modulation of iron homeostasis through the repression of iron-responsive element-binding protein 2
Hui-Jun Zhou,Junru Chen,Mingjie Fan,Huajian Cai,Yufei Dong,Yue Qiu,Qianqian Zhuang,Zhaoying Lei,Mengyao Li,Xue Ding,Peng Yan,Aifu Lin,Shusen Zheng,Qingfeng Yan +13 more
TL;DR: In this article , the authors found fluphenazine is an activator of Krüpple-like factors (KLF) in hepatocellular carcinoma (HCC) cells, which inhibited HCC cells growth through inducing iron deficiency.
Partial Inhibition of HO-1 Attenuates HMP-Induced Hepatic Regeneration against Liver Injury in Rats
Ning He,Jun-Jun Jia,Haiyang Xie,Jianhui Li,Yong He,Shengyong Yin,Ruo-Peng Liang,Li Jiang,Jing-feng Liu,Kangdi Xu,Zhi-hao Zhang,Lin Zhou,Shusen Zheng +12 more
TL;DR: Results suggest that inhibition of HO-1 mitigates HMP-induced liver recovery effects related to proliferation, in part, by downregulating the HGF-Akt axis.
'Druggable' alterations detected by Ion Torrent in metastatic colorectal cancer patients.
Weijia Fang,Milan Radovich,Yulong Zheng,Cai‑Yun Fu,Peng Zhao,Chengyu Mao,Yi Zheng,Shusen Zheng +7 more
TL;DR: Results indicated that DNA sequencing of key oncogenes and tumor suppressors enables the identification of ‘druggable’ alterations for individual colorectal cancer patients.
Pulmonary lymphangitic carcinomatosis in liver carcinoma: a rare case report and literature review
TL;DR: The case of a patient with PLC after liver transplantation due to liver carcinoma was reported, confirmed by clinical manifestations, imaging studies and cytologic examination of exfoliated cells in the pleural effusion.